Get started
Author

Anna Dolnik

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
2019 · Eugen Tausch, William Close, et al. · Haematologica · 210
PDF
Clonal evolution of acute myeloid leukemia with FLT3 -ITD mutation under treatment with midostaurin
2021 · Laura K. Schmalbrock, Anna Dolnik, et al. · Blood · 174
PDF
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing
2012 · Anna Dolnik, Julia C. Engelmann, et al. · Blood · 153
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
2018 · Hartmut Döhner, Anna Dolnik, et al. · Leukemia · 133
PDF
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax
2020 · Eugen Tausch, Christof Schneider, et al. · Blood · 127
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
2019 · Sibylle Cocciardi, Anna Dolnik, et al. · Nature Communications · 125
PDF
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
2019 · T. J. Ettrich, D. Schwerdel, et al. · Scientific Reports · 117
PDF
MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences
2018 · Alberto L′Abbate, Doron Tolomeo, et al. · Leukemia · 105
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML
2019 · Daniel Sasca, Jakub Szybinski, et al. · Blood · 94
PDF
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
2017 · Susanne Hirsch, Tamara J. Blätte, et al. · Haematologica · 93
PDF
getITD for FLT3-ITD-based MRD monitoring in AML
2019 · Tamara J. Blätte, Laura K. Schmalbrock, et al. · Leukemia · 82
PDF
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication
2020 · Nikolaus Jahn, Tobias Terzer, et al. · Blood Advances · 74
Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype
2017 · Frank G. Rücker, Anna Dolnik, et al. · Haematologica · 71
PDF
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
2022 · Yuen Lam Dora Ng, Evelyn Ramberger, et al. · Nature Communications · 67
PDF
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
2020 · Maurice Reimann, Jens Schrezenmeier, et al. · Blood · 59
ProSAP-interacting Protein 1 (ProSAPiP1), a Novel Protein of the Postsynaptic Density That Links the Spine-associated Rap-Gap (SPAR) to the Scaffolding Protein ProSAP2/Shank3
2006 · Doreen Wendholt, Christina Spilker, et al. · Journal of Biological Chemistry · 59
PDF
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemia
2019 · Annika Scheffold, Billy Michael Chelliah Jebaraj, et al. · Blood · 55
PDF
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype
2024 · Aino-Maija Leppä, Karen Grimes, et al. · Nature Genetics · 42
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
2019 · Jennifer Edelmann, Karlheinz Holzmann, et al. · Haematologica · 42
PDF
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1
2020 · Eugen Tausch, Philipp Beck, et al. · Haematologica · 40
PDF
Longitudinal single-cell transcriptomics reveals distinct patterns of recurrence in acute myeloid leukemia
2022 · Yanan Zhai, Prashant Singh, et al. · Molecular Cancer · 39
PDF
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
2024 · Evelyn Ramberger, Valeriia Sapozhnikova, et al. · Nature Cancer · 32
Deregulated expression of circular RNAs in acute myeloid leukemia
2021 · Susanne Lux, Tamara J. Blätte, et al. · Blood Advances · 31
PDF
Functional characterization of BRCC3 mutations in acute myeloid leukemia with t(8;21)(q22;q22.1)
2019 · Tatjana Meyer, Nikolaus Jahn, et al. · Leukemia · 27
PDF
Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3
2015 · Anna Dolnik, Noreen Kanwal, et al. · Journal of Neurochemistry · 27
Works count: 126
Citation count: 2,439
H-index: 26
I10-index: 40
Year
Topic
Type